“It’s a microcosm of a larger broken system, in which you have an R&D system that’s profit-driven rather than people-driven.” MSF’s Dana Gill in @RollingStone on pharma’s history of profiteering – and how #COVID19 presents an opportunity for...

Medicines shouldn’t be a luxury